Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India

NCT07109297 · clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
110
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi